US firms selling unapproved 'stem cell treatments'
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Miami
HUNDREDS of companies across the United States are selling unapproved stem cell treatments directly to patients, raising concerns about safety and scams in a fast-growing industry, researchers said on Thursday.
At least 351 companies across the United States are marketing unapproved stem cell procedures at 570 individual clinics, the researchers' report in the journal Cell Stem Cell found.
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Singaporeans can now buy record amount of yen per Singdollar
